Table 3.
Comparison of lipid profile in BC (pre and post treated) patients with controls
Lipid parameter (mg/dL) | Controls n = 50 | Pre-treated BC patients n = 130 | Post-treated BC patients n = 130 |
---|---|---|---|
TC (<200) | 137.88 ± 24.45 | 224.4 ± 25.21* | 150.2 ± 22.19* ¶ |
TG (<150) | 114.42 ± 24.74 | 144.7 ± 21.28 | 146.2 ± 27.42 |
HDL (<40) | 56.56 ± 14.77 | 55.96 ± 16.97 | 43.36 ± 5.62 ¶ |
LDL(<100) | 54.16 ± 12.71 | 142.9 ± 25.04* | 89.83 ± 26.68* ¶ |
TL (450-1000) | 509.72 ± 37.97 | 718.1 ± 53.74* | 579.7 ± 55.59* ¶ |
VLDL(<30) | 22.67 ± 4.75 | 28.95 ± 4.25* | 31.49 ± 5.71* |
TC:HDL(4.0) | 2.712 ± 0.84 | 4.48 ± 1.60 | 3.54 ± 0.72 |
TC:LDL (1-6) | 2.70 ± 0.91 | 1.59 ± 0.17* | 1.78 ± 0.53 *¶ |
HDL:LDL (0.5) | 1.06 ± 0.45 | 0.39 ± 0.145* | 0.51 ± 0.14 * |
*p < 0.01 shows the comparison between pre-treated and post treated BC patients with controls, ¶ p < 0.01 shows the comparison between pre-treated BC patients with post treated BC patients